Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multifunctional Role of Chymase in Acute and Chronic Tissue Injury and Remodeling
Louis J. Dell’Italia, James F. Collawn, Carlos M. Ferrario
Circulation Research (2018) Vol. 122, Iss. 2, pp. 319-336
Open Access | Times Cited: 99

Showing 26-50 of 99 citing articles:

Angiotensin Dysregulation in Patients with Arterial Aneurysms
Maria Elisabeth Leinweber, Corinna Walter, Afshin Assadian, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1502-1502
Open Access
Mast cell chymases: essential for preventing the transition from acute to chronic pain
Erick J. Rodríguez‐Palma, Rajesh Khanna
Pain (2025)
Closed Access
Chymase inhibitors for the treatment of cardiac diseases: a patent review (2010–2018)
Sarfaraz Ahmad, Carlos M. Ferrario
Expert Opinion on Therapeutic Patents (2018) Vol. 28, Iss. 11, pp. 755-764
Open Access | Times Cited: 32
Targeting the renin−angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges
Krishna Sriram, Rohit Loomba, Paul A. Insel
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 47, pp. 29274-29282
Open Access | Times Cited: 32
Kinins and chymase: the forgotten components of the renin-angiotensin system and their implications in COVID-19 disease
Zaid Abassi, Karl Skorecki, Dalit B. Hamo‐Giladi, et al.
AJP Lung Cellular and Molecular Physiology (2021) Vol. 320, Iss. 3, pp. L422-L429
Open Access | Times Cited: 26
Diverse biological functions of the renin‐angiotensin system
Adithi Rao, Shabir Ahmad Bhat, Tomohiro Shibata, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 2, pp. 587-605
Open Access | Times Cited: 10
Serum concentration of renin-angiotensin system components in association with ACE I/D polymorphism among hypertensive subjects in response to ACE inhibitor therapy
Mariyana G. Hristova, С. Станилова, Lyuba Miteva
Clinical and Experimental Hypertension (2018) Vol. 41, Iss. 7, pp. 662-669
Closed Access | Times Cited: 25
Proteases in Pemphigoid Diseases
Sho Hiroyasu, Christopher T. Turner, Katlyn C. Richardson, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 25
Monotherapy of RAAS blockers and mobilization of aldosterone: A mechanistic perspective study in kidney disease
Gaurav Gupta, Rajiv Dahiya, Yogendra Singh, et al.
Chemico-Biological Interactions (2020) Vol. 317, pp. 108975-108975
Open Access | Times Cited: 23
Renal Mast Cell-Specific Proteases in the Pathogenesis of Tubulointerstitial Fibrosis
Dmitri Atiakshin, С. Л. Морозов, В. В. Длин, et al.
Journal of Histochemistry & Cytochemistry (2024)
Closed Access | Times Cited: 2
The Angiotensin-(1–12)/Chymase axis as an alternate component of the tissue renin angiotensin system
Carlos M. Ferrario, Leanne Groban, Hao Wang, et al.
Molecular and Cellular Endocrinology (2020) Vol. 529, pp. 111119-111119
Open Access | Times Cited: 19
New Targets in Heart Failure Drug Therapy
Michele Correale, Lucia Tricarico, Martino Fortunato, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 16
Binding Loop Substitutions in the Cyclic Peptide SFTI-1 Generate Potent and Selective Chymase Inhibitors
Choi Yi Li, Kuok Yap, Joakim E. Swedberg, et al.
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 2, pp. 816-826
Closed Access | Times Cited: 19
Effects of the chymase inhibitor fulacimstat on adverse cardiac remodeling after acute myocardial infarction—Results of the Chymase Inhibitor in Adverse Remodeling after Myocardial Infarction (CHIARA MIA) 2 trial
Hans-Dirk Düengen, Raymond J. Kim, Doron Zahger, et al.
American Heart Journal (2020) Vol. 224, pp. 129-137
Closed Access | Times Cited: 16
Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction—Results of the CHIARA MIA 1 Trial
Hans‐Dirk Düngen, Lars Køber, Savina Nodari, et al.
Clinical Pharmacology in Drug Development (2018) Vol. 8, Iss. 7, pp. 942-951
Closed Access | Times Cited: 18
Activation of the Human Angiotensin-(1-12)-Chymase Pathway in Rats With Human Angiotensinogen Gene Transcripts
Carlos M. Ferrario, Jessica L. VonCannon, Sarfaraz Ahmad, et al.
Frontiers in Cardiovascular Medicine (2019) Vol. 6
Open Access | Times Cited: 17
Effects of the chymase inhibitor fulacimstat in diabetic kidney disease—results from the CADA DIA trial
Peter Rossing, Jorma Strand, Angelo Avogaro, et al.
Nephrology Dialysis Transplantation (2020) Vol. 36, Iss. 12, pp. 2263-2273
Closed Access | Times Cited: 15
Targeting the Protective Arm of the Renin-Angiotensin System: Focused on Angiotensin-(1–7)
Sana Khajehpour, Ali Aghazadeh‐Habashi
Journal of Pharmacology and Experimental Therapeutics (2021) Vol. 377, Iss. 1, pp. 64-74
Open Access | Times Cited: 13
Protease profile of normal and neoplastic mast cells in the human bone marrow with special emphasis on systemic mastocytosis
Dmitri Atiakshin, Igor Buchwalow, Peter Horny, et al.
Histochemistry and Cell Biology (2021) Vol. 155, Iss. 5, pp. 561-580
Open Access | Times Cited: 13
The pathogenic role of c-Kit+ mast cells in the spinal motor neuron-vascular niche in ALS
Mariángeles Kovacs, Catalina Alamón, Cecilia Maciel, et al.
Acta Neuropathologica Communications (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 13
Autoantibodies to IgE can induce the release of proinflammatory and vasoactive mediators from human cardiac mast cells
Remo Poto, Vincenzo Patella, Gjada Criscuolo, et al.
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 4, pp. 1265-1276
Open Access | Times Cited: 9
Impact of early pericardial fluid chymase activation after cardiac surgery
Brittany Butts, Lee A. Goeddel, Jingyi Zheng, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 5
Potassium Intake Prevents the Induction of the Renin-Angiotensin System and Increases Medullary ACE2 and COX-2 in the Kidneys of Angiotensin II-Dependent Hypertensive Rats
Alexis A. González, Matias Gallardo, Carlos Céspedes, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 15
Kounis Syndrome as First Manifestation of Allergic Sensitization
D Forlani, Gilda Scarano, A D‘Alleva, et al.
Case Reports in Medicine (2019) Vol. 2019, pp. 1-5
Open Access | Times Cited: 14
Twenty years of progress in angiotensin converting enzyme 2 and its link to SARS-CoV-2 disease
Carlos M. Ferrario, Sarfaraz Ahmad, Leanne Groban
Clinical Science (2020) Vol. 134, Iss. 19, pp. 2645-2664
Open Access | Times Cited: 14

Scroll to top